about
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary diseaseAre ICD-10 codes appropriate for performance assessment in asthma and COPD in general practice? Results of a cross sectional observational studyImpact of bronchodilator therapy on exercise tolerance in COPD.Daily exposure to dust alters innate immunityPositive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations.Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication AdherenceLong-acting inhaled beta 2-agonists for stable COPD.Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease.A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.Effect of theophylline associated with short-acting or long-acting inhaled beta2-agonists in patients with stable chronic obstructive pulmonary disease: a systematic review.Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines.Effects of a care protocol on care outcomes in older nursing home patients with chronic obstructive pulmonary disease.Advances in the understanding and future therapy of COPD
P2860
Q24245413-5BE2A40A-63A2-4897-8FFD-A8B0C6493955Q24805263-BAE80B25-AA54-43F8-BEAE-72E73DE5A955Q33831434-A67E4BF0-B9C1-4A80-86D6-D6AE5B898D89Q34166427-A5C36A12-D4DA-4A15-A1B4-48F783534F4FQ34558280-B02A8A04-4C65-42B9-80A4-79375D911197Q34770001-3E0EF6E7-689F-40DB-BAA0-A1757C6D568BQ35008081-839E5C04-3C7D-44A7-BA49-B23B314729D8Q35201031-EC9A5A1F-5E38-4DBE-AC67-F77D7BF2C23DQ35205369-D9A7DB7F-CA74-4516-9905-545B4CF01568Q36272434-781357A3-9289-42FF-95AE-216FA790E9E4Q36921279-C63D190C-DBDE-47B5-8E79-EACE5B068545Q38068880-FBDAFE0A-5B15-459F-8A88-87066A560658Q39459241-F2AF5D9E-596E-4211-8BA9-ACF23300DA86Q45937938-10F6BD32-E50B-43AD-ADD9-E3B6E1B1541FQ51716043-E12AD6F0-0E6A-45C4-A7C9-3CEFE8CA88BDQ58877295-F00F9999-61F3-4C66-A5DD-43351980C694
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recommendations for the management of COPD.
@ast
Recommendations for the management of COPD.
@en
type
label
Recommendations for the management of COPD.
@ast
Recommendations for the management of COPD.
@en
prefLabel
Recommendations for the management of COPD.
@ast
Recommendations for the management of COPD.
@en
P1433
P1476
Recommendations for the management of COPD.
@en
P2093
Ferguson GT
P304
P356
10.1378/CHEST.117.2_SUPPL.23S
P407
P433
P577
2000-02-01T00:00:00Z